Here is the synopsis of our sample research paper on Alternative Approaches: EDTA Chelation Therapy. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 5 page paper discussing the use of intravenous ethylenediaminetetraacetate (EDTA) for the treatment of atherosclerosis and other conditions. Chelation therapy has been researched and used for more than 40 years, but it continues to be condemned by the medical establishment that cannot profit from it as much as it can from bypass surgery, hypertension prescriptions and cholesterol-lowering drugs. Medicare and private insurers prefer to pay >$40,000 for bypass surgery rather than paying less than $4000 for chelation therapy. The situation is not seen as holding any promise for change in the near future. Individuals will need to continue to seek out chelation therapy on their own and pay for their own treatments. Bibliography lists 7 sources.
Page Count:
5 pages (~225 words per page)
File: CC6_KSchelation.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
been used - and accepted - for decades. An outgrowth of that approach to detoxification has been the use of intravenous ethylenediaminetetraacetate (EDTA) for the treatment of atherosclerosis.
The practice has been researched for decades as well, and it is gaining growing acceptance as an alternative treatment for arterial disease. It does not meet the criteria that
the medical community has established for mainstream medical practice, however. The American Medical Association (AMA) consistently denounces EDTA chelation therapy as being little more than hocus-pocus; most MDs familiar
with the term with it refuse to discuss it at all. Proponents of the therapy claim that it is the political machine of
medicine that prevents EDTA chelation therapy from becoming the first treatment of choice for arterial disease. As the therapy comes to be more widely used, practitioners have noticed other
benefits. Some patients have experienced increased blood flow to the brain, others have been able to avoid amputation. EDTA chelation therapy appears to provide a means by which
Medicare could greatly reduce its payments to care providers. What EDTA Chelation Therapy Is This is not a quick-fix solution to conditions that
have taken years to develop. The most vocal proponent of the treatment, Elmer M. Cranton, M.D., maintains that the only effective method of gaining positive results is through the
use of intravenous delivery of EDTA over a three-hour period. The intravenous delivery typically occurs two or three times a week for the first several weeks before reducing frequency
to once or twice a week. A full course of treatment generally is considered to consist of 30 IV infusions costing about $115 each.
...